Subtype
Digestive System Adenocarcinoma
CI-CAN-00002525Explore in graph →
1,374 active trials24 approved drugs77 evidence items
- NCIt
- C210140
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002525Explore in graph →
Clinical trials
5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (619)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01666145 | Advanced Image Guidance Utilized in Liver Surgery | completed | N/A | 14 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT02704130 | TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma | terminated | N/A | 8 | Wake Forest University Health SciencesOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT04675866 |
| Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer |
| unknown |
| N/A |
| 46 |
| Henan Cancer HospitalOTHER_GOV |
| 1 |
| Apr 15, 2022 |
| clinicaltrials |
| NCT05323929 | The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma | recruiting | N/A | 200 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03852836 | Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images(BiliFast) | terminated | N/A | 53 | IHU StrasbourgOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04659005 | Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening | completed | N/A | 178 | Chinese University of Hong KongOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT03105921 | Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma | completed | N/A | 20 | Poitiers University HospitalOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04231929 | BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.(BIOPEARL-FIRST) | withdrawn | N/A | 0 | Terumo Europe N.V.INDUSTRY | 1 | Mar 28, 2022 | clinicaltrials |
| NCT01340105 | Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation | completed | N/A | 93 | Chinese University of Hong KongOTHER | 1 | Mar 21, 2022 | clinicaltrials |
| NCT01512407 | RCT on Adjuvant TACE After Hepatectomy for HCC(A-TECH) | completed | N/A | 58 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT01759901 | Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma | completed | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT04602299 | Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors | completed | N/A | 2,000 | Changhai HospitalOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05281783 | RFA for Treatment of Intermediate Stage HCC | completed | N/A | 120 | Benha UniversityOTHER | 1 | Mar 16, 2022 | clinicaltrials |
| NCT05277675 | Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)(RANT) | unknown | N/A | 160 | Southwest Hospital, ChinaOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT05275985 | 68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma | unknown | N/A | 80 | Peking Union Medical College HospitalOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT03979547 | EXALT: EXercise Attenuates Liver Tumors Trial(EXALT) | terminated | N/A | 3 | Milton S. Hershey Medical CenterOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT05270642 | Plan for Microwave Thermal Field | unknown | N/A | 5 | Chinese PLA General HospitalOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04212286 | Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC | completed | N/A | 115 | Tianjin Third Central HospitalOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT03322280 | TACE Combined With Iodine-125 Seeds Implantation for HCC | unknown | N/A | 270 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Mar 3, 2022 | clinicaltrials |
| NCT03784417 | EUS-guided Laser Ablation in Pancreatic Adenocarcinoma | terminated | N/A | 5 | Catholic University of the Sacred HeartOTHER | 1 | Feb 28, 2022 | clinicaltrials |
| NCT05242757 | Clinical Study of MAK Immune Cells in the Treatment of PHC | unknown | N/A | 12 | Zhongnan HospitalOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT01804998 | Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy | completed | N/A | 580 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 15, 2022 | clinicaltrials |
| NCT04722120 | Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC | completed | N/A | 68 | Seoul National University HospitalOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT02009176 | Laparoscope Anatomical and Aon-anatomical Hepatectomy | unknown | N/A | 110 | Shuguo Zheng, MDOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05118451 | A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | unknown | N/A | 420 | Zhujiang HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05233358 | HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure | unknown | N/A | 176 | The Central Hospital of Lishui CityOTHER | 0 | Feb 10, 2022 | clinicaltrials |
| NCT05162898 | Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma. | unknown | N/A | 90 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 27, 2022 | clinicaltrials |
| NCT05068076 | Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC | completed | N/A | 21 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT03731910 | Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE | unknown | N/A | 35 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT04847726 | Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma | completed | N/A | 110 | Seoul National University HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT03113955 | STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma | completed | N/A | 109 | Varian Medical SystemsINDUSTRY | 1 | Dec 1, 2021 | clinicaltrials |
| NCT05121571 | The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study | completed | N/A | 114 | Sun Yat-sen UniversityOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT01357525 | SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma | completed | N/A | 50 | David A. Clump, MD, PhDOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT02787187 | Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? | completed | N/A | 230 | Ruijin HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT03949777 | Validation of Aer-O-Scope Colonoscope System Cecal Intubation | completed | N/A | 79 | GI View Ltd.INDUSTRY | 1 | Nov 18, 2021 | clinicaltrials |
| NCT03926039 | Sharing Decision-making Program for HCC Patients Treatment Decisions | completed | N/A | 70 | National Taipei University of Nursing and Health SciencesOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05017922 | Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma | completed | N/A | 89 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05001360 | Study of FMT Combined With Nivolumab in Gastric Cancer | withdrawn | N/A | 0 | Fujian Cancer HospitalOTHER_GOV | 1 | Oct 27, 2021 | clinicaltrials |
| NCT01141478 | Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria(HCC) | terminated | N/A | 8 | Loma Linda UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT05077358 | Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon Resection | unknown | N/A | 241 | Yonsei UniversityOTHER | 1 | Oct 14, 2021 | clinicaltrials |
| NCT01387503 | Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | completed | N/A | 74 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01642446 | Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension | completed | N/A | 160 | Sun Yat-sen UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04311047 | Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI(NANO-PANC) | terminated | N/A | 26 | Radboud University Medical CenterOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT03591705 | TACE-HAIC vs. HAIC for Potentially Resectable HCC | unknown | N/A | 240 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04531228 | TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial(Thalen) | unknown | N/A | 60 | Yunfei YuanOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT05053386 | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma | unknown | N/A | 186 | Zhejiang Cancer HospitalOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04891874 | Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI | completed | N/A | 76 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05038397 | A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial(Therasphere) | completed | N/A | 30 | MedicalExcellenceOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04003181 | The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon | completed | N/A | 64 | University of AarhusOTHER | 1 | Sep 8, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Apr 22, 2022source: clinicaltrials